The Lancet Oncology
The Lancet Oncology is the global leader in clinical oncology publishing peer-reviewed research and reviews, comment, news, and Commissions. IF=35·9.
🌐 thelancet.com/journals/lanonc/home
- 🆕 Greater transparency for oncology clinical trials reporting Chief Editors of The Lancet’s specialty journals discuss enhanced scrutiny in the reporting of oncology clinical trials Read here: thelancet.com/journals/lan...
- ✏️February's Editorial - Cancer: another casualty of geopolitical unrest? We discuss the deprioritisation of health care during geopolitical instability www.thelancet.com/journals/lan...
- 🆕Our Feb issue is live! 📉Articles: #NSCLC, #glioblastoma, #prostatecancer, #oesophagealcancer, and #coloncancer 📰Reviews: International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression AND ReCOG consensus on multiple courses of RT thelancet.com/issue/S1470-...
- 🆕Our Feb issue is live! 📉Articles: #NSCLC, #glioblastoma, #prostatecancer, #oesophagealcancer, and #coloncancer 📰Reviews: International Multidisciplinary Consensus Group for Malignant Spinal Cord Compression AND ReCOG consensus on multiple courses of RT thelancet.com/issue/S1470-...
- Reposted by The Lancet Oncology[Not loaded yet]
- Join our webinar on Feb 4, Improving Outcomes for Children with Serious Illness through Applied Qualitative Research Hosted by @stjuderesearch.bsky.social in collaboration with @thelancetoncol.bsky.social@thelancethaem.bsky.social @eclinicalmed.bsky.social stjudeglobal.zoom.us/meeting/regi...
- As part of The Lancet Group’s partnership with IARC WHO for the #IARC60 Cancer Research into Action Conference, 19-21 May, 2026, @eclinicalmed.bsky.social will be publishing a best of special issue of conference abstracts Submit your abstract by 19 Jan iarc2026conf.iarc.who.int/en/abstracts...
- @thelancetoncol.bsky.social, @thelancetph.bsky.social, @eclinicalmed.bsky.social are excited to partner with IARC for: #IARC60 Cancer Research into Action Conference Lyon, France, 19-21 May Submit your abstract by 19 Jan: iarc2026conf.iarc.who.int/en/abstracts... For more: iarc2026conf.iarc.who.int
- @thelancetoncol.bsky.social, @thelancetph.bsky.social, @eclinicalmed.bsky.social are excited to partner with IARC for: #IARC60 Cancer Research into Action Conference Lyon, France, 19-21 May Submit your abstract by 19 Jan: iarc2026conf.iarc.who.int/en/abstracts... For more: iarc2026conf.iarc.who.int
- 🔴Online: Aumolertinib as adjuvant therapy in resected EGFR-mutated #NSCLC (ARTS): a double-blind, multicentre, randomised, controlled, phase 3 trial 📉Article thelancet.com/journals/lan... ✏️Comment thelancet.com/journals/lan...
- Reposted by The Lancet Oncology[Not loaded yet]
- 🔴Online now: Cilta-cel in lenalidomide-refractory #multiplemyeloma (CARTITUDE-4): an updated analysis including OS from an open-label, multicentre, randomised, phase 3 trial thelancet.com/journals/lan...
- 🔴Online first: A new Comment from Clare Turnbull and colleagues on the PATHFINDER2 study of GRAIL's Galleri multicancer detection blood test thelancet.com/journals/lan...
- ✏️Our Jan 2026 Editorial: Cancer consequences of the HIV funding crisis "Beyond the already devastating impact on the global burden of HIV, the disruptions seen in 2025 could have consequences beyond HIV and AIDS alone..." www.thelancet.com/journals/lan...
- 🆕Our Jan 26 issue! 📈Articles: #endometrialcancer, #NSCLC, #glioma, #prostatecancer, #oesophagealcancer, #pancreaticcancer 📄Reviews: Framework for glioma surgery by PIONEER and RANO resect 🖱️https://www.thelancet.com/issue/S1470-2045(25)X0013-9 2026 cover artist: J Specht (IG@ ju.liaspecht)
- 🆕Our Jan 26 issue! 📈Articles: #endometrialcancer, #NSCLC, #glioma, #prostatecancer, #oesophagealcancer, #pancreaticcancer 📄Reviews: Framework for glioma surgery by PIONEER and RANO resect 🖱️https://www.thelancet.com/issue/S1470-2045(25)X0013-9 2026 cover artist: J Specht (IG@ ju.liaspecht)
- 🔴Online now: FET-PET-guided versus contrast-enhanced T1-weighted MRI-guided re-irradiation in patients with recurrent #glioblastoma (GLIAA/NOA-10 ARO2013-01): a multicentre, open-label, randomised trial www.thelancet.com/journals/lan...
- The Call for Abstracts for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026 is open Deadline for abstract submission: 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int
- 🎉We're excited to announce our partnership with #IARCWHO for the #IARC60 Cancer Research into Action Conference, in Lyon, France, 19-21 May, 2026!🎉 Accepting abstract until 19 Jan 2026 iarc2026conf.iarc.who.int/en/abstracts... More info on the conference website: iarc2026conf.iarc.who.int
- @thelancetoncol.bsky.social's highlights from the San Antonio Breast Cancer Symposium 2025, #SABCS25 Including trials ELEVATE, ASCENT-07, EPIK-B5, and DETECT V thelancet.com/journals/lan...
- ✏️This month's Editorial: Making prostate cancer screening fit for purpose www.thelancet.com/journals/lan...
- 🚨Our Dec issue is live! - thelancet.com/issue/S1470-... 📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma 📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials
- 🚨Our Dec issue is live! - thelancet.com/issue/S1470-... 📊Articles: #lungcancer, #breastcancer, #hepatocellularcarcinoma, #rectalcancer, #glioma 📑Reviews including neurocognitive outcomes in patients with brain metastases AND SISAQOL-IMI consensus guidelines on PROs in trials
- 🔴Online: Artificial intelligence and radiologists in #pancreaticcancer detection using standard of care CT scans (PANORAMA): an international, paired, non-inferiority, confirmatory, observational study thelancet.com/journals/lan...
- Check out London Global Cancer Week #LGCW2025, running Nov 24 to Nov 28. www.lgcw.org.uk/lgcw-2025/ It's a pleasure for @thelancetoncol.bsky.social to sponsor another year!
- News 🗞️Government shutdown and Medicare changes impact cancer care in the USA, reported by Sharmila Devi www.thelancet.com/journals/lan... 🗞️More e-cigarette users than cigarette smokers for the first time in the UK, reported by Manjulika Das www.thelancet.com/journals/lan...
- 📊Online now: Effectiveness of NELSON versus PLCOm2012 #lungcancer screening eligibility criteria in Germany (HANSE): a prospective cohort study thelancet.com/journals/lan... ✏️Comment: Defining eligibility for lung cancer screening based on individual risk thelancet.com/journals/lan...
- Reposted by The Lancet Oncology[Not loaded yet]
- 🚨Our Nov issue is live - thelancet.com/issue/S1470-... 📊Articles: #breastcancer, #NSCLC, #prostatecancer, #melanoma 📰 Reviews: Tumour-infiltrating lymphocyte therapy in the era of genetic engineering AND AI for Response Assessment in Pediatric Neuro-Oncology (AI-RAPNO)
- 🆕Online: Overall survival assessment in cancer drug trials: a luxury or a necessity? Samuel X Stevens, @lateuwen.bsky.social, and Bishal Gyawali discuss the #FDA draft guidance on overall survival in randomised cancer drug trials thelancet.com/journals/lan...
- 🚨Our Oct issue is live - thelancet.com/issue/S1470-... 📈Articles: on #RCC, #SCLC, #NSCLC, #BladderCancer, #Myeloma, #PancreaticCancer, #EndometrialCancer, and #ThyroidCancer 📝Reviews: EU–CAYAS–NET recommendations for health-care transitions in young people beyond childhood cancer
- No time to wait: resilience as a cornerstone for primary health care across Latin America and the Caribbean, a World Bank-PAHO Lancet Regional Health Americas Commission - The Lancet Regional Health – Americas www.thelancet.com/journals/lan...
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- 🚨Our Sept issue is live - 25 years! thelancet.com/journals/lan... 📊Articles #renalcellcarcinoma, #prostatecancer, #meningioma, #thymiccarcinoma, & #colorectalcancer Reviews: 📰 ESTRO and ASTRO plus endorsed guidelines on vol delineation & 📰 Common Sense Oncology and EORTC on reporting QoL data
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- @thelancetoncol.bsky.social is pleased to announce we are partnering with @estroradiotherapy.bsky.social and Radiotherapy and Oncology for a second year at next year’s Congress in Stockholm. Please submit your abstracts! www.estro.org/Congresses/E...
- Super session announcing a new @thelancet.com @iaslc.bsky.social Commission on lung cancer at this year’s WCLC 2025 in Barcelona
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- 🔴Online today: Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic #colorectalcancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial thelancet.com/journals/lan...
- 🗞️News: Kenya adopts digitally enabled cancer-care model, Paul Adepoju reports “This is just the beginning...What we're building is not just software. It's a system that puts people at the centre.” Lucy Mithu (Roche East Africa) told The Lancet Oncology www.thelancet.com/journals/lan...
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- Reposted by The Lancet Oncology[Not loaded yet]
- 🚨Online today: Prognostic and predictive value of baseline PSMA-PET total tumour volume and SUVmean in metastatic castration-resistant #prostatecancer in #ENZAp (ANZUP1901): a substudy from a multicentre, open-label, randomised, phase 2 trial www.thelancet.com/journals/lan...
- 🚨Clinical picture quiz: An 89-year-old patient was referred urgently following a 10-day headache. The patient recalled that colon cancer had been diagnosed 2 weeks earlier, and a basal cell carcinoma of the head 3 years earlier
- 🔴Perspective: The fight against burnout: @doctorsindistress.bsky.social "Burnout is a silent killer that demands urgent and sustained action...Addressing this crisis requires systemic changes, collective advocacy, and compassion-driven interventions." www.thelancet.com/journals/lan...
- 📢Our Aug issue is now live: thelancet.com/issue/S1470-... 📊Original research #prostatecancer, contraceptive use and #livercancer, #rectalcancer, #colorectalcancer, #myeloma, #hodgkinlymphoma, paediatric NS tumours, and #breastcancer 📖Reviews #endometrialcancer management and PET imaging
- 🔴Online now: HER2DX and survival outcomes in early-stage HER2-positive #breastcancer: an individual patient-level meta-analysis www.thelancet.com/journals/lan...
- Online: Metformin for patients with metastatic #prostatecancer starting androgen deprivation therapy: a randomised phase 3 trial of the STAMPEDE platform protocol @cancerresearchuk.org, @mrcctu.bsky.social www.thelancet.com/journals/lan...
- Online first: Oral contraceptive use and risk of #livercancer: a population-based study, systematic review, and meta-analysis thelancet.com/journals/lan... Linked comment: Oral contraceptives and risk of liver cancer thelancet.com/journals/lan...
- We are an internationally trusted source of clinical and global oncology. While a partial measurement of our impact, we are pleased to share our Impact Factor of 35·9 and CiteScore of 50·8. hubs.li/Q03vcVf50
- July Editorial: Politics and pharma—hurdles in UK science ambitions 🔬In June, the UK government announced plans to boost science and technology research and development; however, a stand-off with the pharmaceutical industry over profits threatens these plans www.thelancet.com/journals/lan...
- July Perspectives: You are her son, not her doctor, Nicholas W Eyrich describes his experience of having a loved one receive a life-threatening diagnosis bit.ly/4knc36G AND Solutions for tackling the global surgery crisis in west Africa, Leo Cheng and colleagues bit.ly/4kjJuH8
- July issue: Zanidatamab plus chemotherapy as first-line treatment for patients with HER2-positive advanced gastro-oesophageal adenocarcinoma: primary results of a multicentre, single-arm, phase 2 study www.thelancet.com/journals/lan...
- July issue: Hormone therapy use and young-onset #breastcancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group 🖱️ www.thelancet.com/journals/lan...
